Your current location:HOME >business >Why Amylyx is pulling ALS drug Relyvrio from US market after study 正文
TIME:2024-05-21 19:34:57 Source: Internet compilationEdit:business
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Brazil replaces injured goalkeeper Ederson in Copa America squad2024-05-21 19:12
FAU's Vladislav Goldin to join Dusty May at Michigan, pulls name out of NBA draft2024-05-21 18:22
Huairou set for Beijing film festival2024-05-21 17:59
China to hold first space cooperation forum with LatAm, Caribbean countries2024-05-21 17:55
The fightback begins: Boss of London's Queen Mary University tells pro2024-05-21 17:52
Not just for trolls! Four2024-05-21 17:49
DPRK successfully test2024-05-21 17:33
Hamas official says no agreement with Israel if war continues in Gaza2024-05-21 17:13
A warrant for Netanyahu’s arrest was requested. But no decision was made about whether to issue it2024-05-21 17:09
Huairou set for Beijing film festival2024-05-21 17:06
Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue2024-05-21 19:17
Chinese FM holds talks with Bolivian counterpart2024-05-21 18:58
Entire mall in Georgia is closed after 'shots are fired inside2024-05-21 18:49
'Flying Apsaras' takes flight in Beijing, set for nationwide tour2024-05-21 18:42
What's next for Iran after death of its president in crash?2024-05-21 18:14
GOP lawmakers in Kansas are moving to override the veto of a ban on gender care for minors2024-05-21 17:33
Not just for trolls! Four2024-05-21 17:26
Chinese FM holds talks with Bolivian counterpart2024-05-21 17:21
Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed2024-05-21 16:54
Immersive Studio Ghibli exhibition opens in Shanghai2024-05-21 16:50